2,2,2-Trichloro-1-(1-ethyl-4-nitro-1H-pyrrol-2-yl)-ethanone, 95.0%, 1g

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzofuran, 95.0%, 250mg

7-(3-((tert-Butyldimethylsilyl)oxy)propyl)-6-(1-ethoxyvinyl)-5-(p-tolyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 98%, 50mg

2-Methylbenzofuran, 95.0%, 25g

2-Methylstilbene>98.0%(GC)1g

L-ValinaMide, N,N-diMethyl-L-valyl-N-[(1S,2R)-4-(1,1-diMethylethoxy)-2-Methoxy-1-[(1S)-1-Methylpropyl]-4-oxobutyl]-N-Methyl-, 98%, 250mg

Ethyl 2-morpholinoacetate, 95.0%, 100g

Recipientes de reactivos para pipetas de 8/12 canales, estériles, 20 piezas, 20 piezas

Báscula compacta serie CX, 1 g, 2200 g, CX2200

4-Bromo-6-fluoroisoquinoline, 97%, 250mg

Cyclopropylmethanesulfonamide, 95.0%, 250mg

2-Chloro-4-isopropoxybenzoic acid, 95+%, 500mg

6-chloro-1-(4-cyanophenyl)-1-oxohexane, 97.0%, 1g